OpenAlex
PricingAboutJobs
Log inGet started
Work

Computational discovery and preclinical validation of a novel nanodrug eEF2 kinase inhibitor for suppression of tumor growth in triple-negative breast cancer by induction of ferroptosis and apoptosis

HTML

Year: 2026
Type: article
Source: International Journal of Biological Macromolecules
DOI: 10.1016/j.ijbiomac.2026.151860
Authors: Ferah Comert Onder, Nermin Kahraman, Pinar Siyah, Serdar Durdağı, Esen Bellur Atici, Pinar Atalay, Sayra Dilmac, Rumeysa Ozyurt, Goknur Kara, Ogun Gul, Izabela Fokt, Waldemar Priebe, Mustafa Guzel, Mehmet Ay, Bulent Ozpolat
Institutions: Çanakkale Onsekiz Mart Üniversitesi, The University of Texas MD Anderson Cancer Center, Bahçeşehir University, Biruni University, Houston Methodist, Houston Methodist Research Institute, Istanbul Medipol University, University of Oklahoma
Language: English

Topic: Computational Drug Discovery Methods
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
SDG: Good health and well-being

Open Access status: closed

Funders: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, National Institutes of Health, National Cancer Institute
Awards: G2577015486, G3274534390
OpenAlex ID: W7150776190
FWCI: 3.591
Cites: 52
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms